KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Novavax (NVAX) Assets Average (2016 - 2025)

Historic Assets Average for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Novavax's Assets Average fell 2873.56% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year decrease of 2873.56%. This contributed to the annual value of $1.7 billion for FY2024, which is 1721.48% down from last year.
  • As of Q3 2025, Novavax's Assets Average stood at $1.3 billion, which was down 2873.56% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Novavax's Assets Average ranged from a high of $2.7 billion in Q2 2022 and a low of $1.3 billion during Q3 2025
  • For the 5-year period, Novavax's Assets Average averaged around $2.0 billion, with its median value being $1.8 billion (2024).
  • Per our database at Business Quant, Novavax's Assets Average surged by 73645.43% in 2021 and then tumbled by 4086.07% in 2023.
  • Quarter analysis of 5 years shows Novavax's Assets Average stood at $2.6 billion in 2021, then fell by 11.99% to $2.3 billion in 2022, then fell by 23.67% to $1.7 billion in 2023, then fell by 5.26% to $1.6 billion in 2024, then fell by 23.11% to $1.3 billion in 2025.
  • Its Assets Average was $1.3 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.4 billion in Q1 2025.